Enanta Pharmaceuticals reported $450.44M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acorda Therapeutics ACOR:US $ 466.09M 25.41M
Amgen AMGN:US $ 64993M 5220M
Anika Therapeutics ANIK:US $ 352.93M 10.2M
AstraZeneca AZN:LN 107221M 33580M
Biocryst Pharmaceuticals BCRX:US $ 265.76M 11.52M
Biogen BIIB:US $ 23806.7M 663.7M
Bristol Myers Squibb BMY:US $ 110893M 96M
Clovis Oncology CLVS:US $ 508M 64.23M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Halozyme Therapeutics HALO:US $ 1185.42M 159.56M
Heron Therapeutics HRTX:US $ 352.39M 51.86M
Insmed INSM:US $ 1.31B 81.99M
Intercept Pharmaceuticals ICPT:US $ 523.07M 0.15M
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Ligand Pharmaceuticals LGND:US $ 1273.66M 17.37M
Marinus Pharmaceuticals MRNS:US $ 158.87M 33.88M
Neurocrine Biosciences NBIX:US $ 2017.3M 60.9M
Novartis NOVN:VX SF 121209M 2806M
Novavax NVAX:US $ 2565.94M 183.65M
Ptc Therapeutics PTCT:US $ 2007.32M 51.34M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
Vertex Pharmaceuticals VRTX:US $ 12618.74M 397.06M
Vital Therapies VTL:US $ 156.76M 20.7M
YTE INCY:US $ 4198.83M 294.21M